UUID : 5D66C90C-40A9-AF46-89FF-E3194FF4A81E

||||||||IIITICIIGIiiiililliiiilililiiiiliﬁl|||||||||lllllilﬁiililcllim

Ill|||||||||||lllllllllllllllllllllllllllllllllllllllllllllll|||

IllllllllllllIllIllllllllllllllllllllllllllllllllllllllIllllllll
web-1:3

Clinical Case Report CEMDWM Wong,
(For Canal-+30!“ 0‘ Pennant-(u IQ Tiﬂcue) call I “05 %7J/&
8 1'6 :- m LJA [é ﬁll/‘61 b‘é,
l gala/"(74‘sS (£159

9%,.) 14/15/13

Enrormeu umsenq

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the a RESEARCH SUBJECT INFORMATION AND CONSENT

FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution.

a»...—

Name of Physician or Study Coordinator / Signature Date

 

[Clinical Informatioﬂ

 

 

 

 

GENERAL TION
‘Elv' Single Married ' '37?“
Gender I3 Divorced El Widow Blood Pressure Heart Rate
[3 Female / 3
. , V. . . , HISTORY OE PRESENT ILLNESS
Chief Complaints: W; , 1mm s wan new;
Symptoms: \kreunkl’ L553 ; VOW ; \ic'uJ; dwell/‘31»? , {WW-{Die iwcdiclwrn}

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory 60-70 Symptomatic, in bed less than 50% of day
I: 40-50 Symptomatic, in bed more than 50% of day. but u t bed ridden CI 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose

 

 

 

PAST MEDICAL HISTORY
Disorder

Treatment Status

 

 

 

Ij Postmenopausal

 

OBIGYN HISTORY :
Menopausal Status Date of First Menses # of Pregnancies
D Pro-menopausal
£1 Peri~Menopausal Date of Last Menses # of Live Births

 

 

 

 

Cl Other:

Birth Control: a Condom El Oral Contraceptive

EIIUD

 

El Hormone Replacement
Therapy:

 

Status
YES Cl N0

Current Status
:1 YES El N0

Current

El YES NO

. SOCIAL HISTORY

Alcohol

TYPE

l Bowie em
Use

'i

Duration

Y MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA. . .

Test Result I Date l .. l Test Result Date
HIV jailNegative (:1 Positive: CEA :3 Negative [3 Positive:

Hep B imNegative El Positive: CA 15-3 El Negative EJ Positive:

Hep C ﬁNegative D Positive: CA 39-9 Cl Negative Ci Positive:
AFP Cl Negative El Positive: PSA CI Negative E] Positive:

Other: [1 Negative D Positive: Other: [3 Negative El Positive:

B/T Cell Markers:

 

 

 

DIAGNOSTIC STUDIES
Results

Ultrasound
x-
CT

\l‘t h‘f'it .1 (Nil; C ’1 \"s
CLINICAL DIAGNOSIS

n
Location of

Clinical Diagnosis
1' N ,5, M Stage: 17: fl}

 

 

[Treatment Information]
SURGICAL TREATMENT

KAha): NM 6' if; 24 53m

Tumor
Detailed Size

X X. cm

Extension of Tumor

L Nodes

of L Nodes # of L Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes

Distant Metastasis
Detailed

I
r N M

N EOADJUVENT THERAPY
Route

 

Pathology Form

 

l§pecimen Information]:

 

 

 

 

 

 

 

 

 

 

 

Collected by: _ Date: __‘ .Time: _
/
Preserved by: _ ﬂ V Date: ”Time;
SPECIMEN TYPE (# of samples provided)
Frozen Parafﬁn Block Blood/Serum/Plasma _> __ Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
'Time to LN: Time to Formalin . Time to w;__ _ ‘ .
' '/ﬂ min / / min min

 

 

 

 

Notes:

 

. PATHOLOGICAL DESCRIPTION
Tumor
Size Extension of Tumor
“x cm

Nodes
Examined

Distant Metastasis
Location

 

 

 

Consolidated Pathology Diagnosis

Vascular

File

+ .. L
Cell Cell

Fibroblast Small Cell
RS
Inﬂam.

Differentiation: :1 Moderate a Poor

0 I II

Giant Cell
Mitotic

    

Nuclear Grade:

I), {5’ 0‘2, o b 3 DZ} W
[Final Pathology Regglj /

Histological Diagnosiswmmmade: 1

Comments:

   

 

 

 

 

Date

Director, Research Pathology

INTEGRATED REPORT OF FINDINGS B:

 

